Description
Light in weight and small in size. Suitable for use in clinics and hospitals
Intended Purpose
The FIA8000 Quantitative Immunoassay Analyzer is an In vitro diagnosis instrument uesd to measure biomarkers in human whole blood, serum or plasma specimens. The test result can be used as an aid in the clinical diagnosis. This instrument can be widely applied in Emergency Room, ICU, CCU, Department of Cardiology, Pediatrics, Geriatrics, Department of Oncology, Heart Surgery, Clinical Laboratories, Community Hospitals, Clinics, First Aid Site and so on.
Together with different Test Devices, it can be used to determine no less than 7 different biomarkers in human blood quantitatively, such as 1) cTnI, 2) NT-proBNP, 3) hs-CRP, 4) CK-MB, 5) Myo, 6) D-Dimer, 7) PCT.
Any interests or questions, please contact us.
Tel：+86-25-68568594
E-mail:sales@getein.com.cn
Website:http://www.bio-gp.com.cn/EN/Index.aspx
bio-equip.cn
Getein Biotech, Inc. (SSE stock code:603387) is a fully integrated in vitro diagnostic company that develops, manufactures and distributes analytical medical devices as well as a broad range of innovative diagnostic test kits, dedicated to making diagnostics more accessible, more affordable, and more equitable for humanity. Since its foundation in 2002, Getein Biotech has launched 10 advanced technology platforms and possesses more than 200 independent intellectual property products. Headquartered in Nanjing, China, Getein Biotech has grown steadily and rapidly in North and South America, Europe, Africa, and the Asia-Pacific region. At present, the products and services of Getein Biotech are available in over 140 countries.
中文
